An international research team led by the Medical University of Vienna has reported a breakthrough treatment strategy that successfully enabled a kidney transplant for a patient who had no realistic chance of receiving a suitable donor organ through conventional methods.
Study finds that kidney transplant recipients treated with remdesivir within a week of COVID-19 diagnosis and receiving at least three consecutive days of therapy experienced fewer cardiovascular complications compared to those who did not receive the antiviral treatment.
A landmark study from Northwestern Medicine published July 8, 2026, demonstrates that lung transplants can successfully extend survival for select patients with Stage 4 lung cancer that hasn't spread beyond the lungs, challenging the long-held belief that transplanting organs into advanced cancer patients is too risky.
UPMC and University of Pittsburgh researchers successfully weaned multiple liver transplant patients off all immunosuppressant drugs for over three years using a pre-transplant cell therapy approach, representing a potential breakthrough in organ transplantation.
